Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase

Japanese Heart Journal

Volumn 37, Issue 1, 1996, Pages 33-41

  Derad, Inge ^a   Stierle, Uei ^a   Giannitsis, Evangelos ^a   Potratz, Jürgen ^a   Born, Jan ^a   Djonlagic, Hasib ^a   Fehm, Horst Lorenz ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Continuous ST segment analysis; rtPA; Urokinase; Wash out of creatine kinase

Indexed keywords

ALTEPLASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE ISOENZYME; FIBRINOLYTIC AGENT; HYDROXYBUTYRATE DEHYDROGENASE; PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; ST SEGMENT;

EID: 0029989621     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.37.33     Document Type: Article

References (11)

1. Klootwijk P, Cobbaert C, Fioretti P, et al. Noninvasive assessment of reperfusion and reocclusion after thrombolysis in acute myocardial infarction. Am J Cardiol 1993; 72: 75G-84G.
2. Olson HG. Bedside cardiology and thrombolysis (Editorial comment). J Am Coll Cardiol 1993; 22: 1317-9.
3. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med 1993; 329: 673-82.
4. Krucoff MW, Croll MA, Pope JE, et al. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation 1993; 88: 437-46.
5. Christian TF, Gibbons RJ, Hopfenspirger MR, et al. Severity and response of chest pain during thrombolytic therapy for acute myocardial infarction: A useful indicator of myocardial salvage and infarct size. J Am Coll Cardiol 1993; 22: 1311-6.
6. Hogg KJ, Hornung RS, Howie CA, et al Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST-segment as a non-invasive marker. Br Heart J 1988; 60: 275-80.
7. Karagounis LA, Anderson JL, Sorensen SG, Moreno FL. Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. Am J Cardiol 1994; 73: 16-22.
8. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312: 932-6.
9. Hohnloser SH, Zabel M, Kasper W, et al. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991; 18: 44-9.
10. Kircher BJ, Topol EJ, O'Neill WW, et al. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol 1987; 59: 513-5.
11. Lewis BS, Ganz W, Laramee P, et al. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1988, 62: 20-4